Mike Polark Analyst PerformanceSenior Research Analyst - Medical Devices at Wolfe ResearchMike Polark is a stock analyst at Wolfe Research in the healthcare sector, covering 24 publicly traded companies. Over the past year, Mike Polark has issued 36 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Mike Polark's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mike Polark's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings43 Last 1 YearsBuy Recommendations58.14% 25 Buy RatingsCompanies Covered24 Unique Companies Ratings Distribution43RatingsDistribution of strong buy, buy, hold, and sell ratings by Mike Polark.RatingPercentageCount Strong Buy14.0%6 ratings Buy44.2%19 ratings Hold37.2%16 ratings Sell4.7%2 ratingsOut of 43 total stock ratings issued by Mike Polark at Wolfe Research, the majority (44.2%) have been Buy recommendations, followed by 37.2% Hold, 14.0% Strong Buy, and 4.7% Sell.Best & Worst CallsBest Call000.0%IRTCMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%INSPMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE58.3% of companies on NYSE14 companiesNASDAQ41.7% of companies on NASDAQ10 companiesMike Polark, an analyst at Wolfe Research, currently covers 24 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare24 companies100.0%Mike Polark of Wolfe Research specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES11 companies45.8%LIFE SCIENCES TOOLS & SERVICES11 companies45.8%BIOTECHNOLOGY1 company4.2%HEALTHCARE PROVIDERS & SERVICES1 company4.2% Mike Polark's Ratings History at Wolfe Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSYKStryker8/13/2026Downgrade$347.15Peer Perform$0.0000.00% ROIABTAbbott Laboratories8/13/2026Upgrade$110.92$130.00Outperform$0.0000.00% ROIINSPInspire Medical Systems8/4/2026Boost Price Target$52.22$59.00Neutral$0.0000.00% ROIAVTRAvantor7/30/2026Upgrade$13.82Hold$0.0000.00% ROIRGENRepligen6/2/2026Initiated Coverage$123.10$145.00Outperform$0.0000.00% ROISTVNStevanato Group6/2/2026Initiated Coverage$18.86$21.00Outperform$0.0000.00% ROIRVTYRevvity6/2/2026Initiated Coverage$100.44Peer Perform$0.0000.00% ROITMOThermo Fisher Scientific6/2/2026Initiated Coverage$493.18$535.00Outperform$0.0000.00% ROIAAgilent Technologies6/2/2026Reiterated Rating$136.08Hold$0.0000.00% ROIMTDMettler-Toledo International6/2/2026Initiated Coverage$1,184.17Peer Perform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. WATWaters6/2/2026Initiated Coverage$376.97$425.00Outperform$0.0000.00% ROINTRANatera6/2/2026Initiated Coverage$218.81$260.00Outperform$0.0000.00% ROIGHGuardant Health6/2/2026Initiated Coverage$129.14$150.00Outperform$0.0000.00% ROIWSTWest Pharmaceutical Services6/1/2026Initiated Coverage$315.87$375.00Outperform$0.0000.00% ROIDHRDanaher6/1/2026Downgrade$180.07Peer Perform$0.0000.00% ROIBRKRBruker6/1/2026Initiated Coverage$58.44Peer Perform$0.0000.00% ROIAVTRAvantor6/1/2026Downgrade$9.21$7.00Underperform$0.0000.00% ROICAICaris Life Sciences6/1/2026Downgrade$16.45Peer Perform$0.0000.00% ROIGHGuardant Health6/1/2026Upgrade$130.17Strong-Buy$0.0000.00% ROINTRANatera6/1/2026Upgrade$213.05Strong-Buy$0.0000.00% ROIRGENRepligen6/1/2026Upgrade$121.13Strong-Buy$0.0000.00% ROISTVNStevanato Group6/1/2026Upgrade$18.92Strong-Buy$0.0000.00% ROITMOThermo Fisher Scientific6/1/2026Upgrade$480.62Strong-Buy$0.0000.00% ROIWATWaters6/1/2026Upgrade$371.90Strong-Buy$0.0000.00% ROIWSTWest Pharmaceutical Services6/1/2026Upgrade$312.77$375.00Outperform$0.0000.00% ROIAVTRAvantor6/1/2026Upgrade$9.10Strong Sell$0.0000.00% ROIBSXBoston Scientific5/29/2026Downgrade$49.12Peer Perform$0.0000.00% ROIINSPInspire Medical Systems5/5/2026Lower Price Target$54.77$50.00Neutral$0.0000.00% ROIIRTCiRhythm Technologies2/20/2026Lower Price Target$147.39$200.00Outperform$0.0000.00% ROIINSPInspire Medical Systems2/13/2026Downgrade$59.74Peer Perform$0.0000.00% ROIINSPInspire Medical Systems2/12/2026Set Price Target$68.50$74.00Neutral$0.0000.00% ROIINSPInspire Medical Systems2/12/2026Downgrade$59.74$74.00Neutral$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$47.00Outperform$0.0000.00% ROIINSPInspire Medical Systems12/4/2025Boost Price Target$135.46$180.00Outperform$0.0000.00% ROIINSPInspire Medical Systems11/25/2025Upgrade$117.28$180.00Outperform$0.0000.00% ROIIRTCiRhythm Technologies10/10/2025Boost Price Target$179.55$220.00Outperform$0.0000.00% ROIMDTMedtronic6/30/2025Upgrade$86.19Peer Perform$00.0000.00% ROIBBNXBeta Bionics5/30/2025Initiated Coverage$15.36$20.00Outperform$00.0000.00% ROIINSPInspire Medical Systems5/6/2025Boost Price Target$159.67$236.00Outperform$00.0000.00% ROIIRTCiRhythm Technologies5/2/2025Boost Price Target$108.59$150.00Outperform$000.0000.00% ROITrump's New Dollar (Ad)Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.Watch the free briefing and see the three steps to prepare todayPODDInsulet4/29/2025Downgrade$259.52Peer Perform$000.0000.00% ROIKMTSKestra Medical Technologies3/31/2025Initiated Coverage$23.43$29.00Outperform$00.0000.00% ROIINSPInspire Medical Systems2/11/2025Lower Price Target$180.96$248.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBMO Capital MarketsStifel NicolausCantor FitzgeraldSanford C. BernsteinWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD Cowen Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
